Agilent Technologies (A) Q1 Earnings and Revenues Beat Estimates

Group 1: Earnings Performance - Agilent Technologies reported quarterly earnings of $1.31 per share, exceeding the Zacks Consensus Estimate of$1.27 per share, and showing an increase from $1.29 per share a year ago, representing an earnings surprise of 3.15$1.68 billion for the quarter ended January 2025, surpassing the Zacks Consensus Estimate by 0.86%, and showing a slight increase from $1.66 billion year-over-year [2] - Over the last four quarters, Agilent has consistently surpassed consensus EPS estimates four times and topped consensus revenue estimates three times [2] Group 2: Stock Performance and Outlook - Agilent shares have declined approximately 0.1$1.33 on revenues of $1.65 billion, and for the current fiscal year, it is$5.56 on revenues of $6.83 billion [7] - The estimate revisions trend for Agilent is currently unfavorable, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Group 3: Industry Context - The Medical - Products industry, to which Agilent belongs, is currently ranked in the top 32% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]